Tatva Chintan Pharma Chem Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)
Tatva Chintan Pharma Chem Ltd · Outcome · 19 Oct 2026, 9:22 pm
Tatva Chintan Pharma Chem Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 2,173 (+75.9% YoY | +30.1% QoQ) ■ EBITDA: 407 (+83.2% YoY | +26.0% QoQ) ■ EBITDA Margin (%): 18.7 (+74 bps YoY | -61 bps QoQ) ■ PAT: 215 (+116.3% YoY | +34.2% QoQ) ■ EPS (INR): 9.17 (+116.3% YoY | +34.3% QoQ)
Original exchange filing (PDF)
More announcements from Tatva Chintan Pharma Chem Ltd
- Updated Investor Presentation. · 20 Oct 2026
- Investor Presentation for the quarter and half year ended 30 September 2026. · 19 Oct 2026
- Earnings Call scheduled to be held on Monday, 19 October 2026 at 05:00 p.m. (IST) has been cancelled due to unforeseen circumstances. · 19 Oct 2026
- Outcome Of the Board Meeting Held On 19.10.2026 · 19 Oct 2026
- Enclosed · 19 Oct 2026
- Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. · 16 Oct 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Earnings Call post announcement of .... · 19 Oct 2026
- TATVA CHINTAN PHARMA CHEM LIMITED has informed the Exchange about Board Meeting to be held on 19-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 19 Oct 2026
